Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Codexis Appoints Vice President of Sales and Marketing

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
Appointment of Scott Watson as Vice President.

Codexis, Inc. has announced the appointment of Scott Watson as Vice President of Sales and Marketing, effective May 2013.

Mr. Watson has more than 25 years of experience in sales, marketing and business development, including in the pharmaceutical and fine chemicals markets.

“Scott brings a strong track record of success to Codexis, along with a wealth of knowledge and connections from his various roles in the pharmaceutical and fine chemical industries,” said John Nicols, President and CEO of Codexis.

Nicols continued, “We continue to expand our pharmaceutical business through new collaborations with strategic partners, and this hire will allow us to capitalize on the many opportunities within both the pharmaceutical industry and other complex chemistry markets where our tailored enzymes can provide significant benefits for our customers.”

“Codexis is the world leader in developing biocatalysts for the pharmaceutical industry and I am very excited to be joining the team at this time,” said Scott Watson.

Watson continued, “The opportunities in the pharmaceutical market continue to grow, and I look forward to helping Codexis further expand its presence, in pharmaceutical and other complex chemistry markets, during the coming years.”

Before joining Codexis, Mr. Watson served most recently as the Executive Director of Sales and Marketing at AMPAC Fine Chemicals, a leading manufacturer of custom small molecule active pharmaceutical ingredients.

From 2008 to 2009, Mr. Watson served as Vice President of Sales and Marketing for Girindus, a diverse service company to the pharmaceutical industry, where he was responsible for realigning the company’s sales strategy.

Prior to Girindus, Mr. Watson held sales positions of growing responsibility with various companies, including Aptuit, DSM and Eastman Chemical Company.

Mr. Watson is a former officer in the U.S. Navy and holds a B.S. in Chemistry from the U.S. Naval Academy and an M.B.A. in Finance and Marketing from George Mason University.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Codexis Sign Technology License Agreement with GSK
Codexis to receive up to $25M of initial payments, plus additional milestone and royalty opportunities.
Wednesday, July 16, 2014
Codexis Sells its Hungarian Operations
The Hungarian subsidiary is sold for $1.5 million to Intrexon Corporation.
Friday, March 14, 2014
Codexis Appoints Patrick Yang to Board of Directors
Dr. Yang brings significant experience in pharmaceutical manufacturing and process development.
Friday, February 28, 2014
Purolite and Codexis Announce Collaboration
Purolite Corporation and Codexis, Inc. announced a joint collaboration to develop and market immobilized enzymes for the pharmaceutical industry.
Thursday, July 18, 2013
Successful Scale-Up in the Production of CodeXol® Detergent Alcohols
Codexis and Chemtex achieve key milestone in commercial development of bio-based chemicals from non-food cellulosic biomass.
Tuesday, June 18, 2013
Codexis Selected for Third Presidential Green Chemistry Award in Seven Years
The award, from the U.S. Environmental Protection Agency, is for the development of an efficient biocatalytic process to manufacture simvastatin, a leading drug for treating high cholesterol.
Tuesday, June 19, 2012
USPTO Grants Codexis Patent for Enzymes Used in Hep-C Therapeutics
Highlights how Codexis platform enables breakthrough biocatalytic processes.
Friday, May 18, 2012
Nature Highlights Advancements in Biocatalysis
Highlights potential impact on the production of biofuels, renewable chemicals, and pharmaceuticals.
Friday, May 11, 2012
Codexis Awarded Biofuels Enzyme Patent
Patent is cornerstone for company’s cellulosic biofuels program.
Wednesday, March 28, 2012
Codexis Names Wes Bolsen VP and Chief Marketing Officer
Mr Bolsen will have responsibility for the company's corporate marketing and communications.
Tuesday, December 06, 2011
Veteran Chemical Executive to Lead Codexis do Brasil
Achilles Antonio Clement has been named Director, Latin America with responsibility for managing Codexis' expanding role in Latin America.
Thursday, October 13, 2011
Codexis Licenses new Drug Metabolite Profiling and Lead Diversification Technology from Caltech
Codexis will incorporate the licensed technology in development of new R&D productivity tools for use by the pharmaceutical industry.
Thursday, August 30, 2007
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!